PP

Propanc Biopharma IncOOTC PPCB Stock Report

Last reporting period 31 Dec, 2023

Updated 14 Nov, 2024

Last price

Market cap $B

0

Micro

Exchange

OOTC - OTC

View Section: Price ratios

Propanc Statements

PP

Data from Propanc`s earning releases including common size income statement and balance sheet.

Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.

Key Information:

Report currency:

USD - US dollar

Last reporting period:

31 Dec, 2023

Next reporting period:

30 Mar, 2024

Report frequency:

Quarterly

Earnings release date:

Expected release date:

Propanc Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

B

M

USD (except Earnings per share)

Financial

Revenue


Cost of sales


Gross profit


Research and development


Selling, general and administrative


Total operating expenses


Operating income


Interest expense


Other income


Income before tax


Provision for income taxes


Net income


Diluted earnings per share


Shares outstanding after dilution


2023-12-31
%

100

0

0

0.114

0

0.324

0

0.438

5 %

0

-0.438

-5 %

0

-0.275

0

0

-0.713

-103.2 %

0

-0.129

0

-0.619

-25.4 %

0

-0.026

23.813

2023-09-30
%

100

0

0

0.016

0

0.401

0

0.417

99.1 %

0

-0.417

-99.1 %

0

0.032

0

0

-0.351

53 %

0

0

-0.493

38.8 %

0

-0.045

10.99

2023-06-30
%

100

0

0

0.006

0

0.204

0

0.21

-45.7 %

0

-0.21

45.7 %

0

-0.531

0

0

-0.747

8 %

0

0.001

0

-0.806

0.5 %

0

-0.223

3.608

2023-03-31
%

100

0

0

0.066

0

0.32

0

0.386

-36.5 %

0

-0.386

36.5 %

0

-0.415

0

0

-0.812

-32 %

0

-0.002

0

-0.81

-60.4 %

0

-0.421

1.924

2022-12-31
%

100

0

0

0.075

0

0.533

0

0.608

0

-0.608

0

-0.05

0

0

-0.615

0

-0.129

0

-0.505

0

-0.526

0.96

View Section: Balance Sheet